| III-85 Sirin Yonucu Explaining inter-species differences to anti-PDL1 cancer immunotherapy using a translational quantitative systems pharmacology approach Thursday 09:55-11:20 |
| III-85 Sirin Yonucu Explaining inter-species differences to anti-PDL1 cancer immunotherapy using a translational quantitative systems pharmacology approach Thursday 09:55-11:20 |